Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3276577

Documents

Beta release

Statistics of Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour
Statistics for this year
PeriodVisitsDownloads
20241414
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0600
2024-0733
2024-0833